Logo XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. rna processing
Show results for
Products
Services
Applications

Companies

News
Articles
Books
Videos

Refine by
Date

  • Older

Rna Processing Articles & Analysis

18 news found

mRNA/LNP technology platform company etherna names Bernard Sagaert as Chief Executive Officer and Marijn Dekkers as Chairman of the Board

mRNA/LNP technology platform company etherna names Bernard Sagaert as Chief Executive Officer and Marijn Dekkers as Chairman of the Board

etherna’s integrated technology offering is internationally recognized as key differentiator – proprietary RNA chemistry and customized LNP platforms matched with deep GMP process know-how. ...

ByeTheRNA


Creative Proteomics Leads the Way with Cutting-Edge RNA Pull Down Service

Creative Proteomics Leads the Way with Cutting-Edge RNA Pull Down Service

This transformative service transcends the boundaries of traditional methodologies, empowering researchers to unlock the enigma of cellular mechanisms and disease pathways. RNA-protein interactions, a cornerstone of molecular biology, hold the key to understanding gene regulation, cell signaling, and complex biological processes. ...

ByCreative Proteomics


Multi-protein Expression Service in Insect Cells Now Available at Profacgen

Multi-protein Expression Service in Insect Cells Now Available at Profacgen

Multiprotein complexes are involved in a wide range of cellular processes, including transcription, translation, RNA splicing, signaling cascades, protein trafficking, and degradation. ...

ByProfacgen


CD Genomics Accelerates RNA Research with the Launch of Nanopore Direct Sequencing

CD Genomics Accelerates RNA Research with the Launch of Nanopore Direct Sequencing

Novel gene isoforms, non-coding RNAs, and RNA modifications can now be unveiled, paving the way for groundbreaking discoveries across various biological processes. Nanopore Direct RNA Sequencing offers exceptional long-read capabilities, allowing the sequencing of full-length RNA transcripts without the need ...

ByCD Genomics


BOC Sciences Live Webinar on Sensitive Nucleic Acids: Applications and Chemical Synthesis

BOC Sciences Live Webinar on Sensitive Nucleic Acids: Applications and Chemical Synthesis

It provides a wide scope of RNA-related products and services, such as nucleosides & nucleotides, pseudoUridine & its derivatives, and RNA synthesis support. Its webinar series themed on RNA-related technologies have brought about positive responses over the past two years. ...

ByBOC Sciences


Leveraging protein DNA/RNA interactions in drug discovery

Leveraging protein DNA/RNA interactions in drug discovery

The field of protein DNA/RNA interactions is an expanding area of research. These interactions affect fundamental processes and as a result, relevant protein DNA/RNA processing complexes and their associated mechanisms provide interesting therapeutic targets to researchers. ...

ByCresset Group


BOC Sciences New Promotes: Comprehensive Oligo Synthesis Service Package   

BOC Sciences New Promotes: Comprehensive Oligo Synthesis Service Package  

BOC Sciences has nurtured a renowned sub-brand, BOC RNA, that focuses on RNA technology and its broad prospects in drug discovery. ...

ByBOC Sciences


Calviri Completes Enrollment of 800 Dogs in a Preventative Cancer Vaccine Trial

Calviri Completes Enrollment of 800 Dogs in a Preventative Cancer Vaccine Trial

The double-blinded trial is testing Calviri’s vaccine aimed at broadly preventing cancers in dogs. The VACCS just completed year three of the planned five year trial. It is being conducted at three leading canine oncology centers – the Flint Animal Cancer Center at Colorado State University, the School of Veterinary Medicine at University of Wisconsin-Madison and the University of ...

ByCalviri


Preventive Cancer Vaccine Trial Releases Two-Year Safety Evaluation

Preventive Cancer Vaccine Trial Releases Two-Year Safety Evaluation

Calviri is focused on using frameshift neoantigens derived from errors in RNA processing to provide pioneering products against cancer. The company is a spin out of the Biodesign Institute, Arizona State ...

ByCalviri


Bio-Techne Announces Paper Publication in Annals of Oncology

Bio-Techne Announces Paper Publication in Annals of Oncology

This will likely require a combination of approaches that exploit biomarkers released through different processes. Exosomes are released from living cancer cells as an active metabolic process, and carry RNA, DNA and proteins. ...

ByExosome Diagnostics, Inc.


Calviri Named Most Fundable Company by Pepperdine Graziadio Business School

Calviri Named Most Fundable Company by Pepperdine Graziadio Business School

The Most Fundable Companies initiative is designed to educate founders on the investor diligence process and recognize exceptional entrepreneurs who are solving today’s problems with inventive solutions and are also seeking investment capital to fuel their company’s growth. ...

ByCalviri


Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities

Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities

Calviri is focused on using frameshift neoantigens derived from errors in RNA processing to provide pioneering products against cancer. The company is a spin out of the Biodesign Institute, Arizona State University, located in Tempe, AZ. ...

ByCalviri


Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement

Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement

Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


Cancer Vaccine Start Up, Calviri, Closes Successful Seed Funding

Cancer Vaccine Start Up, Calviri, Closes Successful Seed Funding

Calviri was founded based on the discovery that tumors make frequent and recurrent errors in RNA transcription and processing that create highly immunogenic frameshift peptides (FSPs). ...

ByCalviri


Calviri Awarded NCI Grant for the Development of a New Blood Test That May Predict Responders to Checkpoint Inhibitor Therapies

Calviri Awarded NCI Grant for the Development of a New Blood Test That May Predict Responders to Checkpoint Inhibitor Therapies

Instead of point mutations in DNA, Calviri focuses on frameshift (FS) variants produced through errors in RNA processing, such as mis-splicing. Calviri has demonstrated that these frameshifted peptides are a rich source of highly immunogenic neoantigens. Since there are a limited number of possible FS peptides, they can be predicted and produced in-situ on arrays ...

ByCalviri


Calviri Demonstrates That RNA Processing Errors Are a Rich Source of Tumor Neoantigens for Cancer Vaccines

Calviri Demonstrates That RNA Processing Errors Are a Rich Source of Tumor Neoantigens for Cancer Vaccines

Calviri, Inc., a biotech startup spun out of Arizona State University Biodesign Institute, focused on prevention and treatment of cancer, announced results that demonstrate the potential of a prophylactic vaccine against cancer. The study of RNA processing errors in tumors highlighted that a large number of frameshift neoantigens are produced. ...

ByCalviri


Frost & Sullivan Recognizes Thermo Fisher Scientific for its Superiority in the Global Biobanking Products, Services and Solutions Market

Frost & Sullivan Recognizes Thermo Fisher Scientific for its Superiority in the Global Biobanking Products, Services and Solutions Market

Due to its exceptional expertise in the area of informatics, the processes, including sample collection, processing, testing, storage and data management, can be managed seamlessly. "Whether clients are building, expanding, or sustaining their own in-house biorepositories or needing to outsource the storage of their samples, Thermo Fisher's extensive product and ...

ByFrost & Sullivan


QIAGEN HPV DNA test donation to expand access to cervical cancer screening for women in rural India

QIAGEN HPV DNA test donation to expand access to cervical cancer screening for women in rural India

Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. ...

ByCSRwire - Corporate Social Responsibility Newswire

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About XPRT Media

XPRT is a global industry marketplace and information resource. Online product catalogs, news, articles, events, publications & more.


  • FAQs
  • Company sitemap
  • Category sitemap
XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
Medical XPRT